Last Posted: Oct 28, 2018
- PharmGKB oxycodone pathway published in Pharmacogenetics and Genomics
PHRMGKB, October 2018 - Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine program.
Reynolds Kristen K et al. Personalized medicine 2017 14(3) 221-233 - Pain Awareness Month — September 2018
CDC MMWR, September 13, 2018 - Surveillance for Emerging Threats to Pregnant Women and Infants: Data for Action
CDC Public Health Grand Rounds, September 18, 2018 - Assessment of Epidemiology Capacity in State Health Departments — United States, 2017
CDC MMWR, August 24, 2018 - A pharmacogenetics approach to pain management.
Yoshida Kaori et al. Neuropsychopharmacology reports 2018 Mar 38(1) 2-8 - Impacts of GRIN3A, GRM6 and TPH2 genetic polymorphisms on quality of life in methadone maintenance therapy population.
Wang Ruey-Yun et al. PloS one 2018 13(7) e0201408 - Single Nucleotide Polymorphisms in TAOK3 Are Associated with High Opioid Requirement for Pain Management in Patients with Advanced Cancer Admitted to a Tertiary Palliative Care Unit.
Gutteridge Timothy et al. Journal of pain and symptom management 2018 Jul - The Genomics of Neonatal Abstinence Syndrome.
Cole F Sessions et al. Frontiers in pediatrics 2017 5176 - Effects of Single Nucleotide Polymorphisms on Surgical and Postsurgical Opioid Requirements: A Systematic Review and Meta-Analysis.
Choi Siu-Wai et al. The Clinical journal of pain 2017 Dec 33(12) 1117-1130
.png)
No hay comentarios:
Publicar un comentario